ARMISTICE CAPITAL, LLC - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 146 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2017. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q2 2017$8,900,000
-15.1%
2,000,000
-11.1%
1.13%
-47.6%
Q1 2017$10,485,000
+1.3%
2,250,000
+32.4%
2.16%
-11.6%
Q4 2016$10,353,000
+51.5%
1,700,000
+37.1%
2.45%
+11.7%
Q3 2016$6,832,000
+35.2%
1,240,000
-6.8%
2.19%
+13.9%
Q2 2016$5,054,000
-16.8%
1,330,000
-39.5%
1.92%
-19.3%
Q1 2016$6,072,0002,200,0002.38%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q3 2017
NameSharesValueWeighting ↓
Nantahala Capital Management 11,578,568$20,147,0000.82%
Virtus ETF Advisers LLC 441,461$768,0000.68%
Hikari Power Ltd 2,300,000$4,002,0000.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,403,149$2,441,0000.17%
KNOTT DAVID M 225,400$392,0000.15%
Clear Harbor Asset Management, LLC 277,110$482,0000.09%
Malaga Cove Capital, LLC 97,264$169,0000.09%
Lehman Financial Resources, Inc. 80,800$140,0000.07%
Cheyne Capital Management (UK) LLP 50,000$87,0000.06%
Ballew Advisors, Inc 26,200$46,0000.05%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders